23rd August 2022

Love Hemp Group PLC

("Love Hemp", the "Group", or the "Company")

Issue of Equity Correction

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), the brand-led consumer goods company focused on CBD health and wellness solutions, announces the issue of equity by the Company.

Further to the RNS of 23 August 2022 describing the issuance of 390,480 Ordinary Shares to Mason Media Limited the total number of Ordinary Shares in issue is in fact 1,199,195,111 and not 1,322,995,111 which was incorrectly stated. The figure of 1,199,195,111 should therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

-ENDS-

For further information please visit: www.lovehempgroup.com or contact:

Love Hemp Group                                +44 (0) 203 968 6643

Tony Calamita                                       investor.relations@lovehempgroup.com

About Love Hemp Group

Love Hemp Group is a brand-led consumer goods company focussed on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics and topicals. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE: LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life, to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.

Market Abuse Regulation (MAR) Disclosure

This information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.